Gutfreund John Peter
SEC CIK 1940797 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IMDX | Insight Molecular Diagnostics Inc. | Former Dir | 0 | $48.0K | — | 6 | 2022-08-15 | 2023-06-30 |
Most active insiders at IMDX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Bradsher Neal C | 10% | $3.00M | — |
| 2 | BROADWOOD PARTNERS, L.P. | 10% | $2.69M | — |
| 3 | James Andrea S. | CFO | — | — |
| 4 | Riggs Josh | CEO, Pres, Dir | — | — |
| 5 | Liu James Yang | VP ACCT, Cntlr, Treas, PAO | — | — |
| 6 | Last Andrew J. | Dir | — | — |
| 7 | Arno Andrew | Dir | — | — |
| 8 | SILVERMAN LOU | Dir | — | — |
Gutfreund John Peter made no open-market trades at IMDX in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2023-07-03 | 2023-06-30 | IMDX | Insight Molecular Diagnostics Inc. | Gutfreund John Peter | Former Dir | J - Other | $0.00 | -3.09M | 0 | -100% | $0 |
| DI | 2023-04-05 | 2023-04-03 | IMDX | Insight Molecular Diagnostics Inc. | Gutfreund John Peter | Dir | A - Grant | $0.35 | +1.00M | 1.07M | +1,333% | +$350.0K |
| D | 2023-04-05 | 2023-04-03 | IMDX | Insight Molecular Diagnostics Inc. | Gutfreund John Peter | Dir | A - Grant | $0.35 | +705.0K | 715.0K | +7,050% | +$246.7K |
| I | 2022-12-28 | 2022-12-23 | IMDX | Insight Molecular Diagnostics Inc. | Gutfreund John Peter | Dir | P - Purchase | $0.33 | +75.0K | 75.0K | New | +$24.8K |
| D | 2022-08-17 | 2022-08-15 | IMDX | Insight Molecular Diagnostics Inc. | Gutfreund John Peter | Dir | A - Grant | $0.00 | +10.0K | 10.0K | New | $0 |
| DI | 2022-08-17 | 2022-08-15 | IMDX | Insight Molecular Diagnostics Inc. | Gutfreund John Peter | Dir | P - Purchase | $0.93 | +25.0K | 25.0K | New | +$23.2K |
Purchase Sale Sale after option exercise All abbreviations